Amir H. Kalali, MD | Psychiatrist.com

Academic Highlights

Challenges and Solutions in Developing New Medications for Schizophrenia

October 15, 2010

Steven G. Potkin, Adrian Preda, Amir H. Kalali, et al

Original Research

Assessing Onset of Treatment Benefit in Depression and Anxiety: Conceptual Considerations

August 15, 2009

Eugene M. Laska, Craig H. Mallinckrodt, Jim C. Mundt, et al

Original Research

Extended-Release Carbamazepine Capsules as Monotherapy for Acute Mania in Bipolar Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

March 15, 2005

Richard H. Weisler, Alan C. Swann, Andrew J. Cutler, et al

Original Research

A 6-Month, Multicenter, Open-Label Evaluation of Beaded, Extended-Release Carbamazepine Capsule Monotherapy in Bipolar Disorder Patients With Manic or Mixed Episodes

May 1, 2004

Terence A. Ketter, Amir H. Kalali, Richard H. Weisler

Original Research

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Extended-Release Carbamazepine Capsules as Monotherapy for Bipolar Disorder Patients With Manic or Mixed Episodes

April 1, 2004

Richard H. Weisler, Amir H. Kalali, Terence A. Ketter, et al